When people hear about a cancer research breakthrough, the story often sounds simple. A discovery is announced. A new therapy shows promise. A headline declares progress. But what most people don’t see behind cancer research breakthroughs is the long, demanding path that leads to that moment. Scientific progress rarely arrives in a single dramatic leap. It comes through years of incremental work, careful experimentation, and persistence from researchers who are trying to a

Most people think of philanthropy as charity. I think of it as an investment, with an expected return measured in discoveries, not dollars. At the JKTG Foundation, we don’t fund cancer research the traditional way. We don’t issue massive RFPs or wait for consensus to form. We move quickly, prioritize bold thinkers, and stay close to the science. Why? Because the diseases we’re up against, like breast cancer, won’t wait.

We throw the word legacy around a lot. People use it to mean all kinds of things: a name on a building, a career full of accolades, a foundation that writes checks in your honor. But in my experience, real legacy isn’t about how things look. It’s about whether what you built keeps working when you’re no longer in the picture. In cancer research, that’s especially important. If your funding, your connections, or your ideas are holding everything together, then you’re not build